Clinical Trial Update: BREATHE 5-OL: Tracleer (Bosentan) in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing bosentan (Tracleer) in patients with pulmonary arterial hypertension related to Eisenmenger physiology has completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eisenmenger Syndrome
• Pulmonary Arterial Hypertension

Drugs mentioned

• TRACLEER (bosentan)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2016-08-15